Vor Biopharma Inc.

VOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 6, 2026
SCHEDULE 13G Apr 1, 2026
3 Apr 1, 2026 3
SCHEDULE 13D/A Apr 1, 2026
S-8 Mar 30, 2026 S-8
10-K Mar 30, 2026 10-K
8-K Mar 27, 2026 8-K
SCHEDULE 13D/A Mar 16, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
424B3 Feb 5, 2026 424B3
SCHEDULE 13G/A Feb 5, 2026
EFFECT Feb 4, 2026
CORRESP Feb 2, 2026
UPLOAD Jan 30, 2026
S-3 Jan 29, 2026 S-3
8-K Jan 12, 2026 8-K
8-K Jan 2, 2026 8-K
SCHEDULE 13D Dec 23, 2025
4 Dec 19, 2025
4 Dec 19, 2025
4 Dec 19, 2025
← Newer Page 3 of 19 · 463 filings Older →